Mometasone Teva (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasone Teva, is a glucocorticoid presented as a nasal spray for nasal use. It treats allergic rhinitis, including seasonal allergic rhinitis, by reducing inflammation in the nasal passages.

GNH USA supplies Mometasone Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate nasal spray acts on inflammatory pathways of the nasal mucosa to relieve allergic symptoms.

- Allergic rhinitis: decreases nasal congestion, sneezing and itching. - Seasonal allergic rhinitis: controls symptoms triggered by pollen or seasonal allergens. - Perennial allergic rhinitis: provides ongoing relief of chronic nasal inflammation.

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Headache. - Epistaxis (nosebleed). - Throat irritation or dryness. - Cough. - Altered taste or bitter taste.

Serious or Rare Side Effects: - Nasal septal perforation. - Severe allergic reaction (anaphylaxis). - Vision changes such as cataracts or glaucoma. - Adrenal suppression with prolonged high‑dose use. - Opportunistic fungal infection of the nasal passages. - Systemic immunosuppression leading to increased infection risk.

Before using Mometasone furoate nasal spray, consider the following safety measures.

- Pregnancy: consult a healthcare provider as safety data are limited. - Breastfeeding: use only if the potential benefit justifies the potential risk to the infant. - Active nasal infection: avoid use until the infection has resolved. - Surgery: inform the surgeon of nasal steroid use, especially before nasal or sinus procedures. - Long‑term therapy: monitor for signs of adrenal suppression or ocular effects. - Store at room temperature: keep in the original container, protect from moisture and heat.

Mometasone furoate nasal spray can interact with other medicines; review the following.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic corticosteroid exposure. - Live vaccines: nasal steroids may diminish the immune response to the vaccine.

Moderate Interactions (Monitor Closely): - Other intranasal medications (e.g., decongestants): may increase local irritation. - Systemic corticosteroids: additive systemic glucocorticoid effects. - Antifungal azoles: potential for increased mometasone levels.